Amicus Reports Positive Preliminary Data On Plicera For Gaucher Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Amicus and partner Shire hope to grab a share of the $1 billion market now dominated by Genzyme’s Cerezyme.